Avidian Wealth Enterprises LLC cut its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 1.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,507 shares of the company’s stock after selling 121 shares during the quarter. Avidian Wealth Enterprises LLC’s holdings in Colgate-Palmolive were worth $682,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. Creative Planning raised its holdings in Colgate-Palmolive by 2.0% in the third quarter. Creative Planning now owns 218,018 shares of the company’s stock valued at $22,632,000 after buying an additional 4,372 shares during the period. Occidental Asset Management LLC increased its position in shares of Colgate-Palmolive by 25.1% in the third quarter. Occidental Asset Management LLC now owns 3,579 shares of the company’s stock worth $372,000 after acquiring an additional 719 shares in the last quarter. NBC Securities Inc. raised its stake in shares of Colgate-Palmolive by 49.3% in the 3rd quarter. NBC Securities Inc. now owns 5,463 shares of the company’s stock valued at $567,000 after acquiring an additional 1,804 shares during the period. Swedbank AB lifted its holdings in shares of Colgate-Palmolive by 1.4% during the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock valued at $306,246,000 after acquiring an additional 40,324 shares in the last quarter. Finally, Capstone Wealth Management Group LLC boosted its position in Colgate-Palmolive by 3.2% during the 3rd quarter. Capstone Wealth Management Group LLC now owns 9,520 shares of the company’s stock worth $988,000 after purchasing an additional 292 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
CL has been the topic of several research reports. Wells Fargo & Company cut their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Stifel Nicolaus reduced their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday, February 3rd. Raymond James restated an “outperform” rating and issued a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Piper Sandler reduced their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Finally, Barclays decreased their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $101.16.
Colgate-Palmolive Trading Down 0.7 %
NYSE:CL opened at $86.75 on Thursday. The company has a market cap of $70.88 billion, a PE ratio of 24.64, a P/E/G ratio of 4.12 and a beta of 0.44. The business’s 50 day moving average is $90.00 and its two-hundred day moving average is $96.61. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 52 week low of $82.76 and a 52 week high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm earned $0.87 EPS. On average, analysts predict that Colgate-Palmolive will post 3.73 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.31%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Business Services Stocks Investing
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.